News
-
-
-
PRESS RELEASE
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical Corporation to present new interim venous ulcer healing data from VenoValve U.S. trial at VAM2024. Study focuses on treatment of venous disease with innovative bioprosthetic solutions -
-
PRESS RELEASE
Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)
Societe Generale initiates a share buyback program for EUR 279.8 million, aiming for shares cancellation. The transactions will adhere to regulatory standards and were authorized by supervisory authorities -
PRESS RELEASE
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
HBM Healthcare Investments AG shareholders approve all Board of Directors' proposals at the Shareholders’ Meeting. Details on re-elected board members, compensation, and par value repayment announced -
-
-
-
